Jinyu Medicine: The net profit of the semi -annual profit of 2022 was about 1.643 billion yuan, an increase of 55.11% year -on -year

Every time AI News, Jinyu Medicine (SH 603882, closing price: 69.2 yuan) released the semi -annual performance report on the evening of August 17 that the operating income in the first half of 2022 was about 8.312 billion yuan, an increase of 52.37%year -on The net profit of shareholders was about 1.643 billion yuan, an increase of 55.11%year -on -year; the basic earnings per share was 3.53 yuan, an increase of 53.48%year -on -year. The company does not make profit distribution and the provident fund is transferred to the share capital.

From January to December 2021, the operating income of Jinyu Medicine composition: 94.65%of third -party medical diagnosis, and 5.35%of other industries.

The chairman and general manager of Jinyu Medicine are Liang Yaoming, male, 58 years old, and the background of his education is a master's degree.

As of press time, the market value of Jinyu Medicine was 32.2 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. In the past 30 days, Jinyu Medicine has a decrease of 424,800 shares in northern direction, accounting for 0.09%of the proportion of circulating shares;

2. In the past 30 days, there was no research on investigating Jinyu Medicine.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Each headline (NBDTOUTIAO) -This "Kaiqiao" of this old -fashioned economic province: The economic increase in the first half of the year is over the world and Jiangsu.

(Reporter Chen Pengcheng)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -